Skip to main content Back to Top
Advertisement

MCM 2021 Specialty Pharmacy Feature: Navigating Immunotherapy Toxicity Management for Non-Oncology Specialists

Broadcast Date: October 6, 2022

 

Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

In this featurette from the 2021 Midyear Clinical Meeting, our content matter experts compare the toxicities of immunotherapy versus chemotherapy and the timeline for these toxicities to the skin, gastrointestinal, hepatic, renal, pulmonary and endocrine systems and recommend appropriate follow-up for patients with immune-related adverse effects from endocrine systems.

HOST

Jessie HippleJessie Hipple Rosario, PharmD, MMHC, serves as a Director of Member Relations and the liaison to the Section of Specialty Pharmacy Practitioners at ASHP. In this role, Dr. Hipple Rosario serves as the secretary for the Section Executive Committee and leads the development and implementation of strategies and programs to accomplish the objectives established by the Section.

Prior to this role, Dr. Hipple Rosario completed the ASHP Executive Fellowship in Association Leadership and Management under mentorship from ASHP’s Senior Leadership. Dr. Hipple Rosario received her Doctor of Pharmacy along with a Master of Management in Health Care degree from Lipscomb University College of Pharmacy and Health Sciences prior to completing an ASHP accredited PGY1 pharmacy residency at Maury Regional Medical Center in Tennessee. She previously obtained a Bachelor of Science in Toxicology from The Pennsylvania State University.

 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.